Methyltestosterone: Clinical Trials

6 trials of Methyltestosterone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated, 1 not yet recruiting, 1 recruiting. 6 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 26Completed 2, Terminated 2, Not yet recruiting 1, Recruiting 1
Phase 31Not yet recruiting 1

Follow Methyltestosterone: new trials by email Literature Review of Methyltestosterone trials Research Report on Methyltestosterone

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing the Use of High Dose Testosterone Followed by Darolutamide Compared to the Usual Care for Patients With Metastatic Prostate Cancer
Abiraterone Acetate, Biospecimen Collection, Bone Scan - Metastatic Castration-Resistant Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 2 / Phase 3Not yet recruitingECOG-ACRIN Cancer Research Group4322027-01-062026-10-01
Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study
Biopsy Procedure, Biospecimen Collection, Bone Scan - Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 2RecruitingUniversity of Washington692024-05-212026-07-21
Comparison of Estrogen and Methyltestosterone Combination Treatments for Postmenopausal Hot Flushes
Esterified Estrogens (EE) and Methyltestosterone (MT) - Hot Flushes, Menopause, Postmenopause
Phase 2CompletedSolvay Pharmaceuticals12512005-06-012008-08-15
The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women
esterified estrogens 1.25mg and methyltestosterone 2.5mg, Esterified estrogens 1.25 mg - Menopause
Phase 2TerminatedSolvay Pharmaceuticals1332004-07-012008-04-11
The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women
esterified estrogens 1.25 mg and methyltestosterone 2.5 mg, Esterified estrogens 1.25 mg - Menopause
Phase 2TerminatedSolvay Pharmaceuticals282004-07-012008-04-11
Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women
esterified estrogens 0.625 mg and methyltestosterone 1.25 mg - Menopause
Phase 2CompletedSolvay Pharmaceuticals3502004-06-012015-01-16

Conditions studied

Prostatic Neoplasms (2)  ·  Hot Flashes (1)

Sponsors

Solvay Pharmaceuticals (4)  ·  ECOG-ACRIN Cancer Research Group (1)  ·  University of Washington (1)

Countries

United States (5)  ·  Canada (1)  ·  Russia (1)

Top investigators

Michael Schweizer (2)

NIH funding

2005 (1), P50CA097186 (1), U10CA180820 (1)